Buying Guide

Whole Genome vs. Whole Exome Sequencing: Which One Should You Actually Pay For?

The exome is cheaper and reads the 'important' 1-2% — but that framing hides what you give up. Here's the honest comparison.

GenomeTesting.org9 min readUpdated 2026

Once you decide to sequence your DNA, you hit a fork in the road: whole exome sequencing (WES) or whole genome sequencing (WGS)? The exome is cheaper and reads the "important" protein-coding part. But that framing quietly hides what you give up. Here's the honest comparison.

The core difference in one paragraph

Your genome is about 3 billion base pairs. Only around 1–2% of it directly codes for proteins — that protein-coding portion is called the exome. Whole exome sequencing reads just that slice. Whole genome sequencing reads essentially all of it — the coding regions and the vast non-coding majority. The debate is really about whether that other 98% is worth paying for.

FeatureWhole Exome (WES)Whole Genome (WGS)
Coverage~1–2% (protein-coding)Essentially the entire genome
CostLowerHigher (gap has narrowed a lot)
Non-coding / regulatory variantsLargely missedCaptured
Deep intronic variantsOften missedCaptured
Structural & copy-number variantsLimitedDetected more reliably
Coverage uniformityUneven (capture-based)More even
Future re-analysis valueLimited to the exomeHigh — whole genome on file

What the exome catches well

The exome is where a large share of known disease-causing variants live, because changes to protein-coding sequence often have obvious functional consequences. For many diagnostic questions, especially known single-gene disorders, WES is a powerful and cost-effective tool — which is why it's widely used clinically. If your only goal is to look at well-characterized coding variants, the exome does a lot of the job.

What the exome misses — and why it can matter

The counterintuitive part: because WGS coverage is more uniform, it can sometimes read the very coding regions the exome is supposed to specialize in more reliably than WES does. The exome's targeting is a strength for cost and a weakness for consistency.

The future-proofing argument

Here's the point that tips many consumers toward WGS: our ability to interpret the genome keeps improving. A variant that looks meaningless today may be understood tomorrow. If you sequenced only your exome, that future insight can't reach the 98% you never read. With a whole genome on file, you — or a clinician — can re-analyze the same data years later against updated knowledge, without a new sample or a new test. You're buying not just today's answers but access to tomorrow's.

So which should you pay for?

A reasonable way to think about it:

Get Your Complete Genome, Not Just 2% of It

Dante Labs offers full 30x whole genome sequencing — the entire genome, evenly covered, with the raw data yours to keep and re-analyze as the science advances. It's the future-proof choice over an exome-only test.

Get 10% Off Whole Genome Sequencing → Use code GENOME at checkout · Italian lab · Full 30x WGS · You keep the raw data

A note on coverage depth

Whichever you choose, ask about coverage depth — how many times each position is read. Higher depth means more confident variant calls. A quality 30x whole genome reads each position about 30 times on average, which is the consumer standard for reliable results. Depth and breadth are two different axes, and both matter.

This article is for general educational purposes only and is not medical advice. Genetic results should be interpreted with a qualified healthcare provider or genetic counselor. Do not start, stop, or change any medication or treatment based on this article.